Search results :

Ceftriaxone

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: J01DD04

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Pain 9.4% x x x x x x x x x x x x x x
Eosinophilia 4.6% - 6% x x x x x x x x x x x x x x x
Thrombocytosis 5.1% x x x x x x x x x x x x x x
Diarrhoea 2.7% - 3.3% x x x x x x x x x x x x x x x
Leukopenia postmarketing, 2% - 2.1% x x x x x x x x x x x x x x x
Rash postmarketing, 1.3% - 1.7% x x x x x x x x x x x x x x x
Tenderness 1 - 2% x x x x x x x x x x x x x x
Anaphylactic shock postmarketing, 0.1 - 1.0% x x x x x x x x x x x x x x
Anaemia 0.1 - 1.0% x x x x x x x x x x x x x
Headache 0.1 - 1.0% x x x x x x x x x x x x x x x
Pruritus 0.1 - 1.0% x x x x x x x x x x x x x x x
Vaginal inflammation 0.1 - 1.0% x x x x x x x x x x x x x x
Stomach ache 0.1 - 1.0% x x
Agranulocytosis postmarketing x x x x x x x x x x x x x x x
Aplastic anaemia postmarketing x x x x x x x x
Cholestasis postmarketing x x x x x x x x
Dermatitis atopic postmarketing x x x x x x x x x x x x
Oedema postmarketing x x x x x x x x x x x x
Toxic epidermal necrolysis postmarketing x x x x x x x x x x x
Epistaxis 0.1% x x x x x x x x x x x x x x
Erythema multiforme postmarketing x x x x x x x x x x x x
Glossitis postmarketing x x x x x x x x x x x x
Glycosuria 0.1% x x x x x x x x x x x x x x
Haemorrhage postmarketing x x x x x x x x x
Hypersensitivity postmarketing x x x x x x x x x x x
Hypertonia postmarketing x x x x x x x x
Neutropenia postmarketing x x x x x x x x x x x x x x
Oliguria postmarketing x x x x x x x x x x x x
Paraesthesia 0.1% x x
Convulsion postmarketing x x x x x x x x x x x
Serum sickness 0.1% x x x x x x x x x x x x x x
Stevens-Johnson syndrome postmarketing x x x x x x x x x x x x
Stomatitis postmarketing, 0.1% x x x x x x x x x x x x
Superinfection postmarketing x x x x x x x x
Thrombocytopenia postmarketing x x x x x x x x x x x x x x x
Thrombophlebitis 0.1% x x
Urticaria postmarketing x x x x x x x x x x x x
Hepatic function abnormal postmarketing x x x x x x x x
Lactic dehydrogenase activity increased postmarketing x x x x x x x x
Fatal outcomes postmarketing x x x x x x x
Serum sickness-like reaction postmarketing x x x x x x x x
Hyperkinesia postmarketing x x x x x x x x
Prothrombin time shortened 0.1% x x
Nephropathy toxic postmarketing x x x x x x x x
Gallbladder sludge 0.1% x x x x x x x x x x x x x
Drug fever postmarketing x x x x x x x x
Renal impairment postmarketing x x x
Abdominal pain x x x x x x x x x x x x x x
Alveolitis allergic x x x x x x x x x x x
Haemolytic anaemia x x x x x x x x x x x x x
Autoimmune haemolytic anaemia x x
Ataxia x x
Coagulopathy x
Bronchospasm x x x x x x x x x x x x x x
Candida infection x x x x x x x x x x x x x x
Colitis x x x x x x x x x x x x x
Dermatitis x
Dermatitis exfoliative x
Dizziness x x x x x x x x x x x x x x x
Dysgeusia x x x x x x x x x x x x x x
Dyspepsia x x x x x x x x x x x x x x
Enterocolitis x
Body temperature increased x x x x x x x x x x x x x x
Flatulence x x x x x x x x x x x x x x
Flushing x x x x x x x x x x x x x x
Haematuria x x x x x x x x x x x x
Jaundice x x x x x x x x x x x x x x
Laryngeal oedema x x
Leukocytosis x x x x x x x x x x x x x x
Lymphocytosis x x x x x x x x x x x x x x
Lymphopenia x x x x x x x x x x x x x x
Fungal infection x
Nausea x x x x x x x x x x x x x x x
Palpitations x x x x x x x x x x x x x x
Pancreatitis x
Phlebitis x x x x x x x x x x x x
Proteinuria x x
Shivering x x
Vomiting x x x x x x x x x x x x x x x
Chills x x x x x x x x x x x x x x
Monocytosis x x x x x x x x x x x x x x
Crystalluria x
Aspartate aminotransferase increased x x
Blood urine x x
Malaise x x
Burning tongue x x
Induration x x x x x x x x x x x x x x
Anaphylactoid reaction x
Warmth x x x x x x x
Nephrolithiasis x x x x x x x x x x x x x
Secondary infection x
Drug interaction x
Serum creatinine increased x
Sweating increased x x x x x x x x x x x x x x
Basophilia x x x x x x x x x x x x x x
Haematocrit decreased x x
Local reaction x x x x x x x x x x x x
Pseudomembranous colitis x x x x x x x x x x x x x x
Loose stools x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

CEFTRIAXONE SODIUM / ROCEPHIN

Side effects:50
Source:FDA

CEFTRIAXONE

Side effects:51
Source:FDA Structured Product Label

Ceftriaxone Sodium / Ceftriaxone Alphapharm

Side effects:58
Source:medicines.org.au

CEFTRIAXONE

Side effects:71
Source:FDA Structured Product Label

CEFTRIAXONE

Side effects:71
Source:FDA Structured Product Label

CEFTRIAXONE

Side effects:71
Source:FDA Structured Product Label

CEFTRIAXONE

Side effects:71
Source:FDA Structured Product Label

CEFTRIAXONE

Side effects:72
Source:FDA Structured Product Label

CEFTRIAXONE

Side effects:72
Source:FDA Structured Product Label

CEFTRIAXONE

Side effects:73
Source:FDA Structured Product Label

CEFTRIAXONE

Side effects:73
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label